MedPlus Health Services Ltd. (IN:MEDPLUS)
:MEDPLUS
Want to see IN:MEDPLUS full AI Analyst Report?
MEDPLUS Stock Chart & Stats
₹808.80
₹1.40(0.17%)
At close: 4:00 PM EST
₹808.80
₹1.40(0.17%)
Day’s Range― - ―
52-Week Range₹731.95 - ₹1,052.05
Previous CloseN/A
Volume104.47K
Average Volume (3M)39.52K
Market Cap
₹104.47B
Enterprise Value₹125.61B
Total Cash (Recent Filing)₹5.02B
Total Debt (Recent Filing)₹22.04B
Price to Earnings (P/E)41.8
Beta0.44
Next Earnings
Jun 02, 2026EPS Estimate
5.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.35
Shares Outstanding120,054,640
10 Day Avg. Volume11,750
30 Day Avg. Volume39,524
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)5.18
Price to Sales (P/S)1.47
P/FCF Ratio18.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,155.00Price Target Upside42.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)20.47
Revenue Forecast (FY)₹78.05B
Bulls Say, Bears Say
Bulls Say
Omnichannel Pharmacy NetworkMedPlus combines a large physical pharmacy network with digital/omnichannel ordering and home delivery, creating durable customer convenience and repeat prescription capture. This omnichannel reach raises lifetime customer value, expands catchment beyond walk-ins and supports steady throughput per store.
Material Free Cash Flow ImprovementFree cash flow turning materially positive provides lasting financial flexibility: supports reinvestment in stores and tech, funds working capital and debt paydown, and reduces refinancing risk. Reliable cash generation is a durable enabler of strategic growth and balance sheet resilience.
Improved Profitability With Stable Operating MarginsStable EBIT/EBITDA margins alongside improved net profit margin indicate operational control and scalable cost structure. Sustained operating-margin stability supports predictable cash flow and demonstrates ability to absorb investments or price pressures while preserving core profitability.
Bears Say
Gross Profit Margin CompressionA notable decline in gross margin signals pressure on sourcing, pricing or product mix. Persistent gross-margin erosion would reduce operating leverage, squeeze long-term profitability and constrain free cash flow, making it harder to fund store expansion or defend market share.
Rising LeverageModerate but increasing debt levels reduce financial flexibility and raise interest burden risk. If leverage continues to climb, the firm may face constrained capital allocation, higher refinancing risk in stress periods, and reduced ability to invest opportunistically.
Low Net Profit Margin LevelAlthough improving, a 2.45% net margin remains thin for durable returns. Low absolute margins make earnings and cash flow sensitive to cost shocks or margin pressure, limiting internal funding for growth and raising dependence on continued operating improvement to sustain returns.
MedPlus Health Services Ltd. News
MEDPLUS FAQ
What was MedPlus Health Services Ltd.’s price range in the past 12 months?
MedPlus Health Services Ltd. lowest stock price was ₹731.95 and its highest was ₹1052.05 in the past 12 months.
What is MedPlus Health Services Ltd.’s market cap?
MedPlus Health Services Ltd.’s market cap is ₹104.47B.
When is MedPlus Health Services Ltd.’s upcoming earnings report date?
MedPlus Health Services Ltd.’s upcoming earnings report date is Jun 02, 2026 which is in 30 days.
How were MedPlus Health Services Ltd.’s earnings last quarter?
MedPlus Health Services Ltd. released its earnings results on Jan 30, 2026. The company reported ₹5.35 earnings per share for the quarter, beating the consensus estimate of ₹4.8 by ₹0.55.
Is MedPlus Health Services Ltd. overvalued?
According to Wall Street analysts MedPlus Health Services Ltd.’s price is currently Undervalued.
Does MedPlus Health Services Ltd. pay dividends?
MedPlus Health Services Ltd. does not currently pay dividends.
What is MedPlus Health Services Ltd.’s EPS estimate?
MedPlus Health Services Ltd.’s EPS estimate is 5.15.
How many shares outstanding does MedPlus Health Services Ltd. have?
MedPlus Health Services Ltd. has 120,054,640 shares outstanding.
What happened to MedPlus Health Services Ltd.’s price movement after its last earnings report?
MedPlus Health Services Ltd. reported an EPS of ₹5.35 in its last earnings report, beating expectations of ₹4.8. Following the earnings report the stock price went up 3.697%.
Which hedge fund is a major shareholder of MedPlus Health Services Ltd.?
Currently, no hedge funds are holding shares in IN:MEDPLUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MedPlus Health Services Ltd.
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It offers pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; fast-moving consumer goods, such as toiletries, baby care products, soaps, detergents, and sanitizers. The company also provides wholesale cash and carry, and pathological laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. As of March 31, 2021, it operated through 1,659 stores located in the states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, as well as through its online store. The company was incorporated in 2006 and is based in Hyderabad, India.
MEDPLUS Stock 12 Month Forecast
Average Price Target
₹1,155.00
▲(42.80% Upside)
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Sastasundar Ventures Limited
―
Thyrocare Technologies Ltd
―